Childhood rhabdomyosarcoma of the extremity: results of combined modality therapy.
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000628:therapy; D001932:Brain Neoplasms / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005121:Extremities; D005260:Female; D006338:Heart Neoplasms / Q000628:therapy; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000628:therapy; D011379:Prognosis; D011882:Radiotherapy, High-Energy; D012208:Rhabdomyosarcoma / Q000175:diagnosis / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000175:diagnosis / Q000628:therapy*; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide